## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 1.67 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($269.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Factset Research Systems Inc (NYSE:FDS) Organic Revenue Rises 6%**
- Source: FXDailyReport.Com | 20251219T170815 | Bullish | Relevance: 100%
- Factset Research Systems Inc. (NYSE: FDS) reported better-than-expected Q1 FY26 results, with organic revenues increasing 6% year-over-year to $600 million. The company's adjusted earnings per share and revenue both surpassed analyst estimates. FactSet anticipates revenues between $2.423-$2.448 billion and earnings per share of $16.9-$17.6 for fiscal 2026.

**2. Stocks making big moves this week: FactSet, Entegris, XPO, ChargePoint, and Coupang**
- Source: Finviz | 20251219T140756 | Somewhat-Bearish | Relevance: 100%
- This article details the significant stock movements for several companies this week, including FactSet (FDS), Entegris (ENTG), XPO (XPO), ChargePoint (CHPT), and Coupang (CPNG). FactSet fell after mixed Q4 results, Entegris was downgraded by Goldman Sachs, XPO saw a decline following a leadership transition, ChargePoint dropped due to a share sale filing, and Coupang fell amid pressure from a data breach.

**3. FactSet Research Systems Inc. (NYSE:FDS) Q1 2026 Earnings Call Transcript**
- Source: Insider Monkey | 20251219T131013 | Bullish | Relevance: 100%
- FactSet Research Systems Inc. reported strong Q1 fiscal 2026 results, exceeding earnings expectations with an adjusted EPS of $4.51 and 5.9% ASP growth. CEO Sanoke Viswanathan outlined three key priorities: driving commercial excellence, delivering productivity improvements, and solidifying long-term strategy, emphasizing FactSet's strong competitive position fueled by proprietary data, embedded workflows, and AI integration. The company also announced an increase in its share repurchase authorization to $1 billion and reaffirmed full-year guidance.

**4. FactSet Research Systems (NYSE:FDS) Initiates Share Repurchase Program**
- Source: MarketBeat | 20251219T031544 | Neutral | Relevance: 100%
- FactSet Research Systems (NYSE:FDS) has authorized a $600 million share repurchase program, aiming to buy back up to 5.4% of its outstanding shares, suggesting management believes the stock is undervalued. This announcement follows FactSet beating quarterly expectations with $4.51 EPS and $607.6 million in revenue, and setting a robust FY2026 EPS guidance. Despite these positive financial indicators, FactSet's shares fell 7.8% on the day of the announcement, and the stock carries a consensus analyst rating of "Reduce" with a mean price target of $347.90.

**5. FactSet (FDS) Stock Slides After Q1 FY2026 Earnings: Revenue Beat, Guidance Reaffirmed, and a $1 Billion Buyback â€” What Investors Are Watching (Dec. 18, 2025)**
- Source: ts2.tech | 20251219T001040 | Somewhat-Bearish | Relevance: 100%
- FactSet's stock dropped roughly 7% despite beating Q1 FY2026 revenue and adjusted EPS estimates and reaffirming full-year guidance. Investors are weighing steady subscription growth against margin compression due to increased technology and content spending, alongside broader concerns about AI's impact on the financial information market. The company also announced an expanded $1 billion share repurchase authorization but faces cautious analyst sentiment and modest net new organic Annual Subscription Value growth.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Goldman Sachs | $253 | $282 | -10% |
| 2025-12-19 | RBC Capital | $320 | $320 | 0% |
| 2025-12-19 | Stifel | $295 | $372 | -21% |
| 2025-12-17 | Morgan Stanley | $307 | $293 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Goldman Sachs | main | Sell |
| 2025-12-19 | RBC Capital | reit | Sector Perform |
| 2025-12-19 | Stifel | main | Hold |
| 2025-12-17 | Morgan Stanley | up | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 16 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Elevated short interest (8.4%): bears positioning against stock.
2. Long-term trend broken: trading 23.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.67 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 26%). Analyst sentiment negative (3 target cuts vs 1 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.9B |
| Beta | 0.74 |
| 52W Range | $250.50 - $493.00 |
| Short Interest | 8.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.67 |
| Forward P/E | 15.2 |
| Current P/E | 16.5 |
| YoY Growth | 8.5% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 3.7% to -0.3% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.77x), long-term trend not supportive. RSI neutral at 54. OFD pattern: +FTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.29% (CS: 49) | Neutral |
| RSI_14 | 53.8 | Neutral |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 0.770x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $288.61
- **Stop Loss:** $269.31 (6.7% risk)
- **Target:** $307.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 46
- **Position Value:** $13,276.06
- **Portfolio %:** 13.28%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |
| 2024Q4 | $4.28 | $4.37 | +2.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*